Pharmaceutical CAS 32986-56-4 Tobramycin Powder Antibiotics Tobramycin Raw Material Powder Tobramycin

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Tobramycin
• Product Name: Tobramycin
• Name: Tobramycin Powder
• Appearance: White to off-White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 32986-56-4
• Mf: C18h37n5o9
• MW: 467.52
• Density: 1.52
• Melting Point: 178 C
• Boiling Point: 775.4 C at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 5 Ton/Month

Product Description

Pharmaceutical CAS 32986-56-4 Tobramycin Powder Antibiotics Tobramycin Raw Material Powder Tobramycin

 

Product Description

Product Details

Product Name	Tobramycin
CAS No.	32986-56-4
MF	C18H37N5O9
MW	467.52
Appearance and shape	White to off-white powder

Tobramycin is an aminoglycoside antibiotic derived from Streptomyces tenebrarius with bacteriostatic activity. Following active transport into the cell, tobramycin binds irreversibly to a specific aminoglycoside receptor on the bacterial 30S ribosomal subunit and interferes with the initiation complex between messenger RNA and the 30S subunit, thereby inhibiting initiation of protein synthesis, consequently leading to bacterial cell death. In addition, tobramycin induces misreading of the mRNA template causing incorrect amino acids to be incorporated into the growing polypeptide chain, consequently interfering with protein elongation.

Application & Function

Function
Tobramycin is an aminoglycoside antibiotic used to treat various types of bacterial infections, particularly Gram-negative infections.Tobramycin, an aminoglycoside antibiotic, has almost the same antibacterial spectrum as Gentamycin, but enjoys lower nephrotoxicity and otoxicity than Gentamycin. It has high antibacterial activity in Gram-negative bacteria, especially against Pseudomonas  areuginosa. Besides, it exerts synergic effect in combination with Penicillins or Cephalosporins.
Application
Main used for serious infections caused by sensitive bacteria, such as gram-negative bacteria in particular, pseudomonas aeruginosa, escherichia coli and klebsiella pneumoniae caused by burn infection, sepsis, infection of the respiratory system, urinary system infection, gallbladder, biliary infection and serious soft tissue infection.

Specification